Roche extends deadline for Spark Therapeutics shareholders in $4.8B deal
April 03, 2019 at 10:29 AM EDT
Roche received offers representing about 29 percent of Sparks’s outstanding shares before the deadline was extended.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|